Cavidi at IAS 2015 in Vancouver
IAS 2015 will be an opportunity for all those involved in the global response to HIV, including scientists, clinicians, public health experts, community leaders, and media professionals, to meet and examine the latest scientific developments in HIV-related research, and explore how such developments can be realistically applied in implementation programmes.
Cavidi and FHI 360 sign Memorandum of Understanding
FHI 360 is a non-profit, human development organisation dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions.
John Mills Chairman Emeritus of Cavidi awarded Australian honour
Congratulations to Chairman Emeritus, Professor John Mills who has received an Officer in the Order of Australia (AO) for distinguished service to medicine as a researcher and physician in the field of infectious diseases, particularly HIV and AIDS, to medical administration, and to the development of Australia’s biotechnology industry.
How you can help make viral load testing a reality this World Aids Day
The time for viral load testing is now.”For years this has been the focus of this company and each of our employees. Today, it has become policy for developing nations around the world as recommended by the World Health Organization (WHO)… Read full post and view Infographic at http://bit.
Cavidi to support PIH viral load program in Haiti
Partners in Health (PIH) will begin a new viral load testing program in Haiti with the support of Load Zero Foundation (LZF) and Cavidi. The program will begin at the PIH L’Hopital Saint Nicolas (HSN) in Haiti. Cavidi will be helping to train PIH staff and will supply the test assay necessary for the program.
From World Trade Center in Malmö to UN in New York
The HIV virus has puzzled researchers all over the world for decades. After lying latent since the 1930s, the virus broke out 50 years later creating one of history’s worst pandemics. In World Trade Center Cavidi is working with the challenging task of limiting the spread of the virus across the world.
Cavidi supports Diagnostics Access Initiative
Cavidi strongly supports the Diagnostics Access Initiative (DAI) recently launched by UNAIDS and ASLM.
Cavidi participate in 20th International AIDS conference
Cavidi will be present at AIDS 2014 to meet key stakeholders and will have a booth in the exhibition hall. The 20th International AIDS conference will be held in Melbourne Australia from July 20th to 25th.
Cavidi in Swedish TECH20 – top 2% of start ups
The TECH20 winners have been announced - the 20 most cutting edge tech companies in Swedish incubators in 2014. TECH20, examines the Swedish startup scene and chooses the young technology companies with greatest potential for success. The aim of TECH20 is to profile companies with the potential to create new Swedish export successes.
ExaVir Load proven effective for routine Viral Load in India
This was the result of a comparative study carried out by the Department of Microbiology at the All India Institute of Medical Sciences in New Delhi, India. This result is one of a series of studies demonstrating the same conclusions - that ExaVir Load is an effective VL test in resource-limited settings.